超声引导下Tenex系统经皮针刺腱切开术治疗难治性肱骨外上髁炎:短期与长期疗效及影响因素
本研究评估超声引导下Tenex系统经皮针刺腱切开术(USPNT)治疗保守治疗无效的肱骨外上髁炎(LE)的疗效,并分析影响治疗反应的患者因素。37例患者(平均年龄51±9岁,男/女15/22)接受治疗,平均随访531天(范围65-1148天)。结果显示PRTEE和DASH评分显著改善(p<0.001),部分患者疗效持续长达3年;术后物理治疗(PT)与治疗反应显著相关,可解释PRTEE疼痛、功能、总分及DASH评分分别降低60%、68%、59%和50%(p<0.001);未发生肌腱断裂、感染等并发症。
要点
- 超声引导下Tenex USPNT可显著改善难治性LE患者的症状和功能,疗效可持续长达3年。
- 术后物理治疗与更好的治疗反应显著相关,应作为USPNT后的常规推荐。
- 该操作未出现肌腱断裂、感染等并发症,安全性较好。
核心结论
- 超声引导下Tenex系统经皮针刺腱切开术可显著改善难治性肱骨外上髁炎患者的PRTEE和DASH评分,部分患者疗效持续长达3年。
- 术后物理治疗与更好的治疗反应显著相关,可解释PRTEE疼痛、功能、总分及DASH评分分别降低60%、68%、59%和50%(p<0.001)。
- 未观察到肌腱断裂、术后感染或其他并发症。
研究设计与样本
- 单中心前瞻性队列研究,连续纳入38个月(2015年2月至2018年3月)内接受Tenex USPNT的难治性LE患者共37例(平均年龄51±9岁,男/女15/22)。
- 采用PRTEE和DASH问卷在术前及随访时评估疗效,平均随访531天(范围65-1148天)。
- 统计方法包括配对t检验、单因素Tobit回归及多因素Tobit回归(前向选择算法),所有模型均校正术前评分和随访时间。
诊断标准与关键数值
- 疗效评估采用PRTEE和DASH问卷评分,治疗前后评分变化用配对t检验比较(p<0.05为显著)。
- 术后PT对治疗反应的贡献度通过Tobit回归模型计算,分别解释PRTEE疼痛、功能、总分及DASH评分降低的60%、68%、59%和50%(p<0.001)。
临床应用与阅片要点
- 对于保守治疗无效的肱骨外上髁炎,可考虑超声引导下Tenex USPNT作为手术替代方案。
- 术后应推荐患者进行物理治疗,以增强治疗效果。
- 操作在超声引导下进行,利用高频振荡针头清创并抽吸病变肌腱,需注意避免损伤正常肌腱结构。
局限性
- 本研究为单中心、非随机、无对照设计,样本量较小(37例),可能存在选择偏倚。
- 随访时间范围较大(65-1148天),部分患者失访或随访时间不足可能影响结果。
- 未设置对照组,无法直接比较USPNT与手术或其他保守治疗的疗效差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Ultrasound-guided percutaneous needle tenotomy (USPNT) has been proposed as an alternative treatment to surgical intervention for lateral epicondylitis (LE). The Tenex system (Tenex Health Inc., Lake Forest, CA, USA) for USPNT is an ultrasonic device involving a needle which oscillates at high frequency to debride and aspirate diseased tendon under ultrasound image guidance. This investigation evaluates the efficacy of USPNT using the Tenex system for LE refractory to conservative management. We also seek to evaluate patient-specific factors which may correlate with treatment response.
MATERIALS AND METHODS: PRTEE (Patient-Rated Tennis Elbow Evaluation) and DASH (Disabilities of the Arm, Shoulder, and Hand) questionnaires were completed before performing the Tenex USPNT for all consecutive patients over a course of 38 months (Feb 2015-Mar 2018). Patients were contacted for follow-up evaluations. Paired t test was used to evaluate significant changes in treatment response (p < 0.05). The univariate Tobit regression model was applied followed by multivariate Tobit model with forward selection algorithm. All models were adjusted by preoperative score and follow-up duration.
RESULTS: A total of 37 patients (average age 51± 9 years, M/F:15/22) with refractory LE were included (mean follow-up, 531 days; range, 65-1148 days). Tenex USPNT significantly improved PRTEE and DASH scores (p < 0.001). In some patients, this decrease persisted for up to 3 years after intervention. A significant association between treatment response and post-procedure physical therapy (PT) was present. Post-procedure PT contributes to 60, 68, 59, and 50% of reduction in PRTEE pain, function, total scores, and DASH score, respectively (p < 0.001). No tendon ruptures, post-procedural infections, or other complications were noted.
CONCLUSION: USPNT with Tenex significantly improves symptoms and function in individuals with LE even with long-term follow-up for 3 years. Post-procedure PT is associated with improved treatment response and should be considered after USPNT.
引用
- Chalian M, Nacey NC, Rawat U, et al. Ultrasound-guided percutaneous needle tenotomy using Tenex system for refractory lateral epicondylitis; short and long-term effectiveness and contributing factors. Skeletal Radiol. 2021. PMID: 33837827. doi:10.1007/s00256-021-03778-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。